Pjt Partners Stock Performance
PJT Stock | USD 101.41 2.17 2.09% |
PJT Partners has a performance score of 5 on a scale of 0 to 100. The company holds a Beta of 1.02, which implies a somewhat significant risk relative to the market. PJT Partners returns are very sensitive to returns on the market. As the market goes up or down, PJT Partners is expected to follow. PJT Partners currently holds a risk of 1.51%. Please check PJT Partners sortino ratio, semi variance, as well as the relationship between the Semi Variance and rate of daily change , to decide if PJT Partners will be following its historical price patterns.
Risk-Adjusted Performance
5 of 100
Weak | Strong |
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in PJT Partners are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively conflicting forward-looking indicators, PJT Partners may actually be approaching a critical reversion point that can send shares even higher in July 2024. ...more
Actual Historical Performance (%)
One Day Return (2.10) | Five Day Return (4.11) | Year To Date Return 0.98 | Ten Year Return 247.77 | All Time Return 247.77 |
Forward Dividend Yield 0.0097 | Payout Ratio 0.2695 | Forward Dividend Rate 1 | Dividend Date 2024-06-20 | Ex Dividend Date 2024-06-05 |
PJT Partners dividend paid on 20th of March 2024 | 03/20/2024 |
1 | Acquisition by Thomas Ryan of tradable shares of PJT Partners subject to Rule 16b-3 | 03/22/2024 |
2 | Disposition of 5018 shares by Cornwell Kievdi Don of PJT Partners subject to Rule 16b-3 | 03/25/2024 |
3 | PJT Partners Stock Rating Reaffirmed by UBS Group - Defense World | 03/27/2024 |
4 | Acquisition by Cornwell Kievdi Don of tradable shares of PJT Partners subject to Rule 16b-3 | 04/19/2024 |
5 | PJT Partners Inc. Reports Record First Quarter 2024 Results | 05/02/2024 |
6 | Novavax and Sanofi Announce Co-exclusive Licensing Agreement to Co-commercialize COVID-19 Vaccine and Develop Novel COVID-19-Influenza Combination Vaccines | 05/10/2024 |
7 | Ieq Capital LLC Lowers Stock Holdings in PJT Partners Inc. - MarketBeat | 05/14/2024 |
8 | PJT Partners is an Incredible Growth Stock 3 Reasons Why | 05/22/2024 |
9 | PJT Partners Reaches New 1-Year High at 107.57 - MarketBeat | 05/24/2024 |
10 | Why You Might Be Interested In PJT Partners Inc. For Its Upcoming Dividend | 05/31/2024 |
11 | Disposition of 779 shares by Lee Ji-yeun of PJT Partners at 108.4 subject to Rule 16b-3 | 06/03/2024 |
12 | PJT Partners managing partner sells over 1 million in stock | 06/04/2024 |
13 | ProKidney launches 125 million share offering | 06/10/2024 |
14 | ProKidney Announces Pricing of its Upsized 130 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering | 06/12/2024 |
Begin Period Cash Flow | 173.2 M | |
Free Cash Flow | 437.6 M |
PJT |
PJT Partners Relative Risk vs. Return Landscape
If you would invest 9,596 in PJT Partners on March 16, 2024 and sell it today you would earn a total of 545.00 from holding PJT Partners or generate 5.68% return on investment over 90 days. PJT Partners is generating 0.1003% of daily returns assuming volatility of 1.5114% on return distribution over 90 days investment horizon. In other words, 13% of stocks are less volatile than PJT, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
Risk |
PJT Partners Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for PJT Partners' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as PJT Partners, and traders can use it to determine the average amount a PJT Partners' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0664
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | PJT | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
1.51 actual daily | 13 87% of assets are more volatile |
Expected Return
0.1 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
0.07 actual daily | 5 95% of assets perform better |
Based on monthly moving average PJT Partners is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of PJT Partners by adding it to a well-diversified portfolio.
PJT Partners Fundamentals Growth
PJT Stock prices reflect investors' perceptions of the future prospects and financial health of PJT Partners, and PJT Partners fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on PJT Stock performance.
Return On Equity | 0.22 | |||
Return On Asset | 0.15 | |||
Profit Margin | 0.08 % | |||
Operating Margin | 0.17 % | |||
Current Valuation | 3.25 B | |||
Shares Outstanding | 23.99 M | |||
Price To Earning | 16.44 X | |||
Price To Book | 9.09 X | |||
Price To Sales | 3.18 X | |||
Revenue | 1.15 B | |||
Gross Profit | 982.51 M | |||
EBITDA | 191.79 M | |||
Net Income | 145.68 M | |||
Cash And Equivalents | 173.24 M | |||
Cash Per Share | 6.08 X | |||
Total Debt | 330.6 M | |||
Debt To Equity | 0.21 % | |||
Current Ratio | 1.85 X | |||
Book Value Per Share | 7.16 X | |||
Cash Flow From Operations | 441.53 M | |||
Earnings Per Share | 3.67 X | |||
Market Capitalization | 4.05 B | |||
Total Asset | 1.43 B | |||
Retained Earnings | 118.33 M | |||
Working Capital | 550.26 M | |||
Current Asset | 221.1 M | |||
Current Liabilities | 73.47 M | |||
About PJT Partners Performance
To evaluate PJT Partners Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when PJT Partners generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare PJT Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand PJT Partners market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents PJT's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.Last Reported | Projected for Next Year | ||
Days Of Inventory On Hand | 198.05 | 323.09 | |
Return On Tangible Assets | 0.07 | 0.05 | |
Return On Capital Employed | 0.13 | 0.10 | |
Return On Assets | 0.06 | 0.04 | |
Return On Equity | 0.33 | 0.46 |
Things to note about PJT Partners performance evaluation
Checking the ongoing alerts about PJT Partners for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for PJT Partners help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Over 87.0% of the company shares are owned by institutional investors | |
Latest headline from finance.yahoo.com: ProKidney Announces Pricing of its Upsized 130 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering |
- Analyzing PJT Partners' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether PJT Partners' stock is overvalued or undervalued compared to its peers.
- Examining PJT Partners' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating PJT Partners' management team can have a significant impact on its success or failure. Reviewing the track record and experience of PJT Partners' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of PJT Partners' stock. These opinions can provide insight into PJT Partners' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for PJT Stock Analysis
When running PJT Partners' price analysis, check to measure PJT Partners' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PJT Partners is operating at the current time. Most of PJT Partners' value examination focuses on studying past and present price action to predict the probability of PJT Partners' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PJT Partners' price. Additionally, you may evaluate how the addition of PJT Partners to your portfolios can decrease your overall portfolio volatility.